144/1032 - Application of WHO guidelines on optimal blood folate concentrations to prevent NTDs in countries

Organized by: World Health Organization (WHO)
Sunday 15 October 16.30 - 18.30 h. Room 5

Chair

Dr. Lisa Marie Rogers

World Health Organization. Switzerland.


co-Chair

Dr. Michael Cannon

National Center of Congenital and Developmental Disorders. US Centers for Disease Control and Prevention (CDC). USA.


Guideline: Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects

Speaker

Dr. Lisa Marie Rogers

World Health Organization. Switzerland.


How much folic acid intake is needed to prevent folate-sensitive neural tube defects?

Speaker

Dr. Krista Crider

National Center of Congenital and Developmental Disorders, US Centers for Disease Control and Prevention (CDC). USA.


Impact of national and regional red blood cell folate and vitamin B12 concentrations on neural tube defects: Predicted vs observed risk

Speaker

Dr. Jorge Rosenthal

National Center of Congenital and Developmental Disorders. US Centers for Disease Control and Prevention (CDC). USA.


Folate and vitamin B12 status among non-pregnant women of reproductive age in Malawi, 2015-2016

Speaker

Eunice Nyirenda

Ministry of Agriculture and Food Security. Malawi


Folate and vitamin B12 status among non-pregnant women of reproductive age in rural areas in Haryana, India, 2017

Speaker

Dr. Reena Das

Post Graduate Institute of Medical Education & Research. India


Periconceptional Surveillance for prevention of anemia and birth defects in Southern India.

Speaker

Dr Julia Finkelstein

Division of Nutritional Sciences. Cornell University